AGP Executive Report
Last update: 5 hours agoMaternal Care Gap-Filling: MGB is expanding a program that pairs high-risk pregnant patients with support workers to “fill the gaps” in transport, meals, baby supplies, doula and mental health services—aimed at improving outcomes for patients facing worsening prenatal access. Opioid Trend: Massachusetts reports 978 opioid-related overdose deaths in 2025, the lowest since 2013, with a steep drop from the 2022 peak. Medicaid Enforcement: Attorney General Letitia James and partners secured $36.5 million from CVS over Medicaid insulin overbilling, sending money back to state Medicaid programs. Oncology Deal: GSK agreed to buy Boston-based Nuvalent for $10.6 billion, boosting its cancer pipeline and signaling continued pharma consolidation. Transplant Testing Push: iMDx will highlight in-house transplanted-organ rejection testing at the American Transplant Congress in Boston. Health Tech Access: A new free patient platform, “You Might Be a Zebra,” launches in Massachusetts to guide people with craniocervical instability and related rare conditions. Postpartum Mental Health: U.S. postpartum depression rates are rising, with experts urging earlier recognition and treatment beyond “baby blues.” World Cup Health Prep: Massachusetts officials are preparing for public health and safety demands tied to the 2026 tournament.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.